NMC
SGRY icon

Nine Masts Capital’s Surgery Partners SGRY Stock Holding History

Nine Masts Capital’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,648
Closed -$606K – 149
2024
Q4 		$606K Buy
+28,648
New +$752K 0.11% 65

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Nine Masts Capital's SGRY Position: Q1 2025 in Review

Nine Masts Capital sold out of Surgery Partners (SGRY) in Q1 2025, closing a stake of 28,648 shares — an estimated $606K sold.

Nine Masts Capital first reported a position in SGRY in Q4 2024 and held it in 1 quarter. The position peaked at $606K in Q4 2024. 208 funds tracked by Wall St. Rank hold SGRY as of Q1 2025.

  • Nine Masts Capital reported no remaining Surgery Partners position as of Q1 2025 after selling out during the quarter.
  • Nine Masts Capital sold 28,648 Surgery Partners shares in Q1 2025, an estimated $606K.
  • Nine Masts Capital first reported a position in Surgery Partners in Q4 2024 and held it in 1 quarter.
  • Nine Masts Capital's Surgery Partners position peaked at $606K in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2025.

Based on Nine Masts Capital's 13F filing for Q1 2025, filed 13 May 2025.